
Chinese General Practice ›› 2022, Vol. 25 ›› Issue (15): 1863-1868.DOI: 10.12114/j.issn.1007-9572.2022.02.013
Special Issue: 内分泌代谢性疾病最新文章合辑
• Article • Previous Articles Next Articles
Received:2021-10-25
Revised:2022-01-09
Published:2022-03-23
Online:2022-04-07
Contact:
Xiangyun CHANG
About author:
通讯作者:
常向云
作者简介:基金资助:
Add to citation manager EndNote|Ris|BibTeX
URL: https://www.chinagp.net/EN/10.12114/j.issn.1007-9572.2022.02.013
| 组别 | 例数 | 性别(男/女) | 年龄( | BMI( | SBP( | DBP( | FPG〔 | FA〔M(P25,P75),mmol/L〕 | FINS( | CpS( |
|---|---|---|---|---|---|---|---|---|---|---|
| 健康对照组 | 22 | 11/11 | 53.9±5.0 | 24.2±2.1 | 132±19 | 77±11 | 4.86±0.50 | 1.51(1.38,1.63) | 78.73±38.54 | 0.94±0.32 |
| T2DM组 | 21 | 12/9 | 54.9±6.1 | 25.1±2.9 | 130±16 | 81±8 | 9.21±2.40 | 2.77(2.21,3.20) | 60.79±36.19 | 0.86±0.35 |
| 检验统计量值 | 0.220a | -0.559 | -1.214 | 0.416 | -1.376 | -8.119 | -5.614b | 1.571 | 0.723 | |
| P值 | 0.639 | 0.579 | 0.232 | 0.680 | 0.176 | <0.001 | <0.001 | 0.124 | 0.474 | |
| 组别 | HOMA-IR〔M(P25,P75)〕 | LDL-C( | HDL-C( | hsa_circ_0005414〔M(P25,P75)〕 | hsa_circ_0139634〔M(P25,P75)〕 | hsa_circ_0032491〔M(P25,P75)〕 | hsa_circ_0002922( | |||
| 健康对照组 | 2.31(1.14,2.95) | 2.79±0.51 | 1.26±0.28 | 1.159(0.647,1.456) | 1.025(0.698,2.050) | 1.173(0.622,1.490) | 1.108±0.497 | |||
| T2DM组 | 2.76(1.72,5.61) | 2.77±0.66 | 1.30±0.22 | 0.046(0.023,0.081) | 0.445(0.229,0.669) | 5.395(3.837,9.310) | 3.200±2.054 | |||
| 检验统计量值 | -1.264b | 0.115 | -0.598 | -5.612b | -3.377b | -5.248b | -4.543 | |||
| P值 | 0.206 | 0.909 | 0.553 | <0.001 | 0.001 | <0.001 | <0.001 |
Table 1 Comparison of general information,biochemical indicators and relative expression levels of four candidate circRNAs in T2DM Han Chinese and healthy Han Chinese
| 组别 | 例数 | 性别(男/女) | 年龄( | BMI( | SBP( | DBP( | FPG〔 | FA〔M(P25,P75),mmol/L〕 | FINS( | CpS( |
|---|---|---|---|---|---|---|---|---|---|---|
| 健康对照组 | 22 | 11/11 | 53.9±5.0 | 24.2±2.1 | 132±19 | 77±11 | 4.86±0.50 | 1.51(1.38,1.63) | 78.73±38.54 | 0.94±0.32 |
| T2DM组 | 21 | 12/9 | 54.9±6.1 | 25.1±2.9 | 130±16 | 81±8 | 9.21±2.40 | 2.77(2.21,3.20) | 60.79±36.19 | 0.86±0.35 |
| 检验统计量值 | 0.220a | -0.559 | -1.214 | 0.416 | -1.376 | -8.119 | -5.614b | 1.571 | 0.723 | |
| P值 | 0.639 | 0.579 | 0.232 | 0.680 | 0.176 | <0.001 | <0.001 | 0.124 | 0.474 | |
| 组别 | HOMA-IR〔M(P25,P75)〕 | LDL-C( | HDL-C( | hsa_circ_0005414〔M(P25,P75)〕 | hsa_circ_0139634〔M(P25,P75)〕 | hsa_circ_0032491〔M(P25,P75)〕 | hsa_circ_0002922( | |||
| 健康对照组 | 2.31(1.14,2.95) | 2.79±0.51 | 1.26±0.28 | 1.159(0.647,1.456) | 1.025(0.698,2.050) | 1.173(0.622,1.490) | 1.108±0.497 | |||
| T2DM组 | 2.76(1.72,5.61) | 2.77±0.66 | 1.30±0.22 | 0.046(0.023,0.081) | 0.445(0.229,0.669) | 5.395(3.837,9.310) | 3.200±2.054 | |||
| 检验统计量值 | -1.264b | 0.115 | -0.598 | -5.612b | -3.377b | -5.248b | -4.543 | |||
| P值 | 0.206 | 0.909 | 0.553 | <0.001 | 0.001 | <0.001 | <0.001 |
| 因变量 | 自变量 | β | 95%CI | SE | β' | t值 | P值 |
|---|---|---|---|---|---|---|---|
| hsa_circ_0005414 | FPG | -0.171 | (-0.252,-0.090) | 0.040 | -0.554 | -4.262 | <0.001 |
| hsa_circ_0139634 | FA | -0.438 | (-0.734,-0.142) | 0.147 | -0.423 | -2.987 | 0.005 |
| hsa_circ_0032491 | FPG | 0.876 | (0.579,1.173) | 0.147 | 0.655 | 5.956 | <0.001 |
| log2FINS | -1.023 | (-1.993,-0.053) | 0.480 | -0.234 | -2.132 | 0.039 | |
| hsa_circ_0002922 | FPG | 0.281 | (0.096,0.465) | 0.091 | 0.433 | 3.074 | 0.004 |
Table 2 Multiple linear regression analysis of the association of four candidate circRNAs with glucose metabolism related indicators in Han Chinese
| 因变量 | 自变量 | β | 95%CI | SE | β' | t值 | P值 |
|---|---|---|---|---|---|---|---|
| hsa_circ_0005414 | FPG | -0.171 | (-0.252,-0.090) | 0.040 | -0.554 | -4.262 | <0.001 |
| hsa_circ_0139634 | FA | -0.438 | (-0.734,-0.142) | 0.147 | -0.423 | -2.987 | 0.005 |
| hsa_circ_0032491 | FPG | 0.876 | (0.579,1.173) | 0.147 | 0.655 | 5.956 | <0.001 |
| log2FINS | -1.023 | (-1.993,-0.053) | 0.480 | -0.234 | -2.132 | 0.039 | |
| hsa_circ_0002922 | FPG | 0.281 | (0.096,0.465) | 0.091 | 0.433 | 3.074 | 0.004 |
| circRNAs | AUC | 95%CI | 截断值 | P值 | 灵敏度(%) | 特异度(%) | 差异倍数 |
|---|---|---|---|---|---|---|---|
| hsa_circ_0139634 | 0.199 | (0.059,0.339) | -0.90 | 0.001 | 100.0 | 0 | 0.495 |
| hsa_circ_0032491 | 0.968 | (0.914,1.000) | 2.22 | <0.001 | 100.0 | 86.4 | 6.506 |
| hsa_circ_0002922 | 0.844 | (0.720,0.968) | 2.05 | <0.001 | 66.7 | 95.5 | 3.200 |
Table 3 Analysis of the value of four candidate circRNAs for the diagnosis of T2DM in Han Chinese
| circRNAs | AUC | 95%CI | 截断值 | P值 | 灵敏度(%) | 特异度(%) | 差异倍数 |
|---|---|---|---|---|---|---|---|
| hsa_circ_0139634 | 0.199 | (0.059,0.339) | -0.90 | 0.001 | 100.0 | 0 | 0.495 |
| hsa_circ_0032491 | 0.968 | (0.914,1.000) | 2.22 | <0.001 | 100.0 | 86.4 | 6.506 |
| hsa_circ_0002922 | 0.844 | (0.720,0.968) | 2.05 | <0.001 | 66.7 | 95.5 | 3.200 |
| 因素 | β | SE | Wald χ2值 | P值 | OR(95%CI) |
|---|---|---|---|---|---|
| hsa_circ_0139634 | -2.384 | 0.883 | 7.298 | 0.007 | 0.092(0.016,0.520) |
| hsa_circ_0032491 | 1.283 | 0.407 | 9.948 | 0.002 | 3.607(1.625,8.004) |
| hsa_circ_0002922 | 1.630 | 0.566 | 8.295 | 0.004 | 5.105(1.683,15.482) |
Table 4 Univariate Logistic regression analysis of the association of three candidate circRNAs with T2DM in Han Chinese
| 因素 | β | SE | Wald χ2值 | P值 | OR(95%CI) |
|---|---|---|---|---|---|
| hsa_circ_0139634 | -2.384 | 0.883 | 7.298 | 0.007 | 0.092(0.016,0.520) |
| hsa_circ_0032491 | 1.283 | 0.407 | 9.948 | 0.002 | 3.607(1.625,8.004) |
| hsa_circ_0002922 | 1.630 | 0.566 | 8.295 | 0.004 | 5.105(1.683,15.482) |
| [1] |
|
| [2] | |
| [3] |
|
| [4] |
乔晓玲,郗光霞. 遗传学因素对2型糖尿病第一时相胰岛素分泌的影响[J]. 国际内分泌代谢杂志,2021,41(3):216-219.
|
| [5] |
李智明,闻智鸣. 表观遗传学、环境与2型糖尿病之间的关系[J]. 医学研究杂志,2014,43(7):10-11,83.
|
| [6] |
|
| [7] |
|
| [8] |
|
| [9] |
|
| [10] |
|
| [11] |
仝梦维,常向云.新疆维吾尔族T2DM患者外周血circRNA差异表达初步研究[J]. 安徽医科大学学报,2022,57(1):41-46. DOI:10.19405/j.cnki.issn1000-1492.2022.01.009.
|
| [12] |
World Health Organization. Definition,diagnosis and classification of diabetes mellitus and its complications. Part 1:diagnosis and classification of diabetes[R]. Geneva:World Health Organization,1999.
|
| [13] |
|
| [14] |
|
| [15] |
|
| [16] |
|
| [17] |
王思思,李嘉江慧,董晶,等. 2型糖尿病相关环状RNA的筛选与验证研究[J]. 中国糖尿病杂志,2019,27(2):86-90. DOI:10.3969/j.issn.1006-6187.2019.02.002.
|
| [18] |
徐文超,刘建平,狄静,等. 2型糖尿病患者外周血环状RNA差异表达分析[J]. 中国糖尿病杂志,2020,28(12):881-886. DOI:10.3969/j.issn.1006-6187.2020.12.001.
|
| [19] |
|
| [20] |
宁利俐,燕艳,付希英,等. 成人隐匿性自身免疫性糖尿病患者环状RNA差异性表达分析[J]. 中国糖尿病杂志,2020,28(8):561-567. DOI:10.3969/j.issn.1006-6187.2020.08.001.
|
| [21] |
|
| [22] |
|
| [23] |
|
| [24] |
|
| [25] |
|
| [26] |
|
| [1] | HE Yang, YANG Rong, SHEN Can, YI Shanye, LIU Lidi, ZHAO Qian, WAN Zhi, LIAO Xiaoyang. Progress in Research on the Trajectory of Frailty and Its Influencing Factors [J]. Chinese General Practice, 2026, 29(30): 4372-4378. |
| [2] | ZHANG Han, CAI Genshen, FENG Zhengwen, ZHANG Kaiyue, LIAN Dongbo, ZHANG Hua, ZHANG Jing. Evaluating the Availability of Health Services for Obesity Comorbidities under Hierarchical Diagnosis and Treatment in Beijing: a Healthcare Institution Survey Study [J]. Chinese General Practice, 2026, 29(28): 4117-4124. |
| [3] | LI Zhixin, LIU Xiaoyu. Practical Research on Promoting Hierarchical Diagnosis and Treatment Through Collaborative Governance of Medical Quality in Regional Medical Alliance [J]. Chinese General Practice, 2026, 29(28): 4107-4116. |
| [4] | FENG Yachen, LIU Lewei, XUE Jinyue, SUN Xianlin, LIU Huanzhong. Research Progress of Wearable Technology in the Diagnosis and Treatment of Mental Disorders [J]. Chinese General Practice, 2026, 29(27): 4016-4025. |
| [5] | WU Yuqiong, CHU Xiangling, HUANG Youye, SUN Li, JIANG Tian, ZHANG Qiu, HU Honglin. A Case Report and Literature Review of Hepatocyte Nuclear Factor 4α Gene Mutation Leading to Maturity-onset Diabetes of the Young [J]. Chinese General Practice, 2026, 29(27): 4011-4015. |
| [6] | LIU Zhenyu, WANG Wendong, YAO Qing, WANG Jiangmin, CAO Wendong. Analysis of Prevalence and Influencing Factors of Cardiovascular-kidney-metabolic Syndrome among Adults in Haidian District, Beijing [J]. Chinese General Practice, 2026, 29(27): 3969-3975. |
| [7] | LIU Yahui, XU Yanan, YUAN Ling, WU Ligui, ZHOU Yujie, KANG Yubiao. A Scoping Review on Triage for Palliative Care Patients Based on Priority Decision-making [J]. Chinese General Practice, 2026, 29(24): 3538-3544. |
| [8] | ZHANG Xuechao, QI Qi, WU Xinyu, HAN Quanle, LI Lei, DENG Jie, LI Cangtuo, YUE Bocheng, WU Shouling, LI Kangbo. Association between the Atherogenic Index of Plasma and New-onset Chronic Kidney Disease [J]. Chinese General Practice, 2026, 29(24): 3440-3446. |
| [9] | WANG Xinliang, ZOU Nannan, CHEN Nana, WANG Xin. Analysis of Clinical Characteristics and Prognostic Risk Factors in Patients with Pulmonary Mucormycosis Complicated with Diabetes Mellitus [J]. Chinese General Practice, 2026, 29(22): 3154-3161. |
| [10] | ZHANG Ji, LI Ling, ZHOU Jie, WU Yanli, JI Wei, LIU Tao. A Prospective Cohort Study on Relationship between Lipid Accumulation Product and Incidence of Metabolic Syndrome in Adults [J]. Chinese General Practice, 2026, 29(22): 3138-3145. |
| [11] | AN Yanhong, WANG Shidong, LI Xiaoran, GUO Jiayang, WANG Zhe, SHA Peilin, MENG Yijun, LI Xiaoxuan, SHI Xue, YU Zexing, XIAO Yonghua. Study on Risk Factors and Nomogram Prediction Model for Diabetic Kidney Disease: Based on Contrast-enhanced Ultrasound Technology [J]. Chinese General Practice, 2026, 29(21): 2995-3003. |
| [12] | PAN Ziyun, YIN Hao, LIN Zhirou, MAO Jingyi, HUANG Yan, LUO Yanhua, XIAO Jiafu, HU Yin. From Mechanism to Therapy: Diabetic Autonomic Neuropathy [J]. Chinese General Practice, 2026, 29(21): 2982-2988. |
| [13] | SONG Zhenzhen, CHEN Yang, WANG Jiwen, LIU Huishan, SHEN Simeng, SUN Ying, CHEN Xing. Study of Maternal Risk Factors Associated with Neonatal Asphyxia in Late Preterm and Term Infants [J]. Chinese General Practice, 2026, 29(20): 2874-2878. |
| [14] | YAN Wen, ZHANG Hanzhi, JIN Hua, QIAN Jie, YU Dehua. Study on the Diagnosis and Treatment Capacity for Depressive Disorders in Community Health Service Institutions in Shanghai [J]. Chinese General Practice, 2026, 29(20): 2790-2799. |
| [15] | YANG Xiaofeng, LI Xianwen, WU Yanfeng, ZHANG Qian, CHEN Juan, ZHAO Fengjiao. Association of Serum Vascular Endothelial Cadherin Levels with the Risk of Post-stroke Cognitive Impairment in Patients with Acute Ischemic Stroke [J]. Chinese General Practice, 2026, 29(20): 2867-2873. |
| Viewed | ||||||
|
Full text |
|
|||||
|
Abstract |
|
|||||